Effect of elemental diet combined with infliximab dose escalation in patients with Crohn's disease with loss of response to infliximab: CERISIER trial

Podobne zapisy

• Complete mucosal healing of distal lesions induced by twice-daily budesonide 2-mg foam promoted clinical remission of mild-to-moderate ulcerative colitis with distal active inflammation: double-blind, randomized study
  od: Naganuma, Makoto, i wsp.
  Wydane: (2017)
• Correction to: Complete mucosal healing of distal lesions induced by twice-daily budesonide 2-mg foam promoted clinical remission of mild-to-moderate ulcerative colitis with distal active inflammation: double-blind, randomized study
  od: Naganuma, Makoto, i wsp.
  Wydane: (2017)
• Predicting outcomes to optimize disease management in inflammatory bowel disease in Japan: their differences and similarities to Western countries
  od: Kobayashi, Taku, i wsp.
  Wydane: (2018)
• The 2nd edition of consensus statements for the diagnosis and management of intestinal Behçet’s disease: indication of anti-TNFα monoclonal antibodies
  od: Hisamatsu, Tadakazu, i wsp.
  Wydane: (2013)
• First trough level of infliximab at week 2 predicts future outcomes of induction therapy in ulcerative colitis—results from a multicenter prospective randomized controlled trial and its post hoc analysis
  od: Kobayashi, Taku, i wsp.
  Wydane: (2015)